Cargando…

Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study

BACKGROUND: Multiple sclerosis (MS) is characterized by inflammatory lesions in the central nervous system involving pro-inflammatory T-cells. Immune dysregulation is well described in prevalent disease, but it is not known whether this precedes disease development. Bacillus Calmette–Guérin (BCG) va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakken, Ola, Holmøy, Trygve, Stigum, Hein, Myhr, Kjell-Morten, Dahl, Jesper, Heldal, Einar, Meyer, Haakon E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557857/ https://www.ncbi.nlm.nih.gov/pubmed/35278068 http://dx.doi.org/10.1093/ije/dyac039

Ejemplares similares

Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
por: Nakken, Ola, et al.
Publicado: (2023)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
por: Holmøy, Trygve, et al.
Publicado: (2020)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013)

Association of adverse childhood experiences with the development of multiple sclerosis
por: Eid, Karine, et al.
Publicado: (2022)

Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry
por: Benjaminsen, Espen, et al.
Publicado: (2019)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
por: Eid, Karine, et al.
Publicado: (2021)

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
por: Norborg, Hilde, et al.
Publicado: (2021)

Tuberculin Skin Test Distribution following a Change in BCG Vaccination Policy
por: Lee, Sei Won, et al.
Publicado: (2014)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
por: Holmøy, Trygve, et al.
Publicado: (2018)

Strong Interaction Physics
por: CERN. Geneva
Publicado: (2012)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

Comparison of Mantoux and Tine Tuberculin Skin Tests in BCG-Vaccinated Children Investigated for Tuberculosis
por: Pan, Wenli, et al.
Publicado: (2009)

John Strong 1941-2006
Publicado: (2006)

High‐throughput sequencing of immune repertoires in multiple sclerosis
por: Lossius, Andreas, et al.
Publicado: (2016)

Poor Sleep in Patients with Multiple Sclerosis
por: Bøe Lunde, Hanne Marie, et al.
Publicado: (2012)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
por: Lunde, Hanne Marie Bøe, et al.
Publicado: (2017)

A safe protocol for tuberculin test assessment in a country where BCG vaccination is mandatory
por: Ayaz, N Aktay, et al.
Publicado: (2008)

Scar formation and tuberculin conversion following BCG vaccination in infants: A prospective cohort study
por: Dhanawade, Sara S., et al.
Publicado: (2015)

School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay
por: Winje, Brita Askeland, et al.
Publicado: (2008)

Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON(®)TB Gold with tuberculin skin test
por: Winje, Brita Askeland, et al.
Publicado: (2008)

The Association of Cold Ambient Temperature With Fracture Risk and Mortality: National Data From Norway—A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study
por: Dahl, Cecilie, et al.
Publicado: (2022)

Employment among Patients with Multiple Sclerosis-A Population Study
por: Bøe Lunde, Hanne Marie, et al.
Publicado: (2014)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

Directorate-General of Health Services, New Delhi (India). Monthly Report on Tuberculin Testings and BCG Vaccinations
Publicado: (1952)

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
por: Holmøy, Trygve, et al.
Publicado: (2019)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
por: Riemer, Frank, et al.
Publicado: (2023)

Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2020)

Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
por: Myro, Aija Zuleron, et al.
Publicado: (2018)

Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study
por: Willumsen, Johannes Sverre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umm4uhoo1jl9efu0galqi8gv0a